Thanks Clyde for your comments. Even In my short time involved...

Thanks Clyde for your comments.
Even In my short time involved with HC it's obvious that your opinion is well regarded and certainly goes along way towards steadying the ship.

The new management team certainly seem to be a more ohnest bunch and can grasp the concept of time is money.

If I understand your comments correctly, the last trials completed, although phase 2a, were not a legislative requirement, only a concious decision by management to greatly DE-RISK the product, and can now progress straight onto phase 3 in Sept.

If I have read the announcements correctly, I believe that a great deal of prelim work for these next trials to happen/begin in Sept has already been completed. It's really only a matter of recruitment and a couple other small matters.

I still don't understand the share price (although today was somewhat of an improvement) as even if there has been no $$$ amounts spoken of, I reckon it should be around the 20c mark now, if compared to other maleria treatments and what some of the big Pharmas are investing in those.

One day we shall have our reward.